Definium Therapeutics Balance Sheet (2020-2026) | DFTX

Balance Sheet Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)
105.74M154.52M131.70M122.30M110.70M115.30M96.70M249.10M243.13M295.28M271.50M82.85M29.90M19.96M255.30M257.20M
Prepaid Assets (Quarter)
3.68M2.75M3.17M1.83M3.91M3.00M2.90M2.39M4.17M3.14M4.56M4.07M7.88M9.26M6.14M6.78M7.73M7.14M
Current Assets (Quarter)
137.22M123.23M109.09M156.51M146.06M132.41M119.79M120.09M103.87M255.47M247.69M299.36M281.62M221.70M189.14M215.85M419.32M380.56M
Non-Current Assets
Long-Term Investments (Quarter)
33.10M54.90M
Goodwill (Quarter)
19.92M19.92M19.92M19.92M19.92M19.92M19.92M19.92M19.92M19.92M19.92M
Intangibles (Quarter)
6.87M6.09M5.27M4.48M3.69M2.90M2.11M1.32M0.53M
Goodwill & Intangibles (Quarter)
26.79M6.09M5.27M24.40M23.61M2.90M22.03M1.32M20.45M19.92M19.92M19.92M19.92M19.92M19.92M
Other Non-Current Assets (Quarter)
0.33M0.30M0.27M0.23M0.22M0.14M0.53M0.49M0.61M0.61M1.17M1.15M0.86M0.81M
Non-Current Assets (Quarter)
26.79M26.01M25.19M24.40M23.94M23.12M22.29M21.46M20.67M20.06M20.45M20.41M20.53M53.62M75.95M21.07M20.78M20.73M
Assets (Quarter)
164.00M149.23M134.28M180.91M169.99M155.53M142.09M141.55M124.54M275.53M268.14M319.77M302.15M275.32M265.09M236.92M440.10M401.29M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
4.18M3.33M0.73M0.82M2.11M2.32M8.58M7.69M4.14M7.59M2.94M2.15M2.01M2.27M4.22M8.11M5.35M7.13M
Payables (Quarter)
4.18M3.33M0.73M0.82M2.11M2.32M8.58M7.69M4.14M7.59M2.94M2.15M2.01M2.27M4.22M8.11M5.35M7.13M
Accumulated Expenses (Quarter)
6.23M7.23M7.14M7.47M3.20M6.69M9.95M3.50M11.63M9.97M8.23M8.80M6.41M11.50M14.80M19.03M9.47M7.41M
Other Accumulated Expenses (Quarter)
0.00M0.04M0.23M0.09M0.07M0.09M0.09M0.44M0.36M0.29M0.69M0.31M0.28M0.26M0.46M0.50M0.51M0.60M
Total Current Liabilities (Quarter)
10.41M10.56M7.87M26.04M17.89M24.10M35.12M31.15M32.25M65.27M41.85M33.27M38.85M30.48M37.96M65.42M66.70M81.11M
Non-Current Liabilities
Non-Current Debt (Quarter)
14.07M14.13M14.19M24.25M24.31M21.85M22.04M41.19M40.38M40.58M40.77M
Other Non-Current Liabilities (Quarter)
1.93M0.49M1.90M1.28M1.18M1.09M0.99M0.35M0.03M0.01M0.97M22.32M25.16M17.84M0.54M0.52M0.50M0.56M
Total Non-Current Liabilities (Quarter)
10.41M11.94M7.87M26.04M17.89M24.10M35.12M45.22M46.38M79.46M65.13M35.26M35.55M34.67M79.15M105.80M107.28M121.89M
Total Liabilities (Quarter)
12.34M12.43M9.77M27.31M19.08M25.18M36.11M45.57M46.41M79.47M66.10M57.58M60.70M52.52M79.69M106.32M107.77M122.44M
Shareholder's Equity
Total Debt (Quarter)
14.07M14.13M14.19M24.25M24.31M21.85M22.04M41.19M40.38M40.58M40.77M
Common Equity (Quarter)
171.63M164.27M151.66M136.81M124.50M153.59M150.92M130.34M105.97M95.98M78.13M196.06M202.05M262.19M241.45M222.81M185.40M130.60M332.33M278.85M
Liabilities and Shareholders Equity (Quarter)
164.00M149.23M134.28M180.91M169.99M155.53M142.09M141.55M124.54M275.53M268.14M319.77M302.15M275.32M265.09M236.92M440.10M401.29M
Retained Earnings (Quarter)
1.05M-156.12M0.85M-189.56M-194.47M0.64M-248.40M0.78M0.34M0.84M-350.45M-364.14M-398.88M-422.20M-464.97M-532.20M-582.67M-659.80M
Treasury Shares (Quarter)
14.01M0.79M1.74M1.55M1.37M5.95M5.96M5.79M5.46M8.18M